Contact
Oct 29, 2014

BCR Diagnostics Unveils Breakthrough Technology for Fluorescence Amplification


Simple Technology Could Reduce Cost of Fluorescence-based Instrumentation by More than Five-fold


Category: General
Posted by: boris123

Chandler, Arizona, October 30, 2014 - Today BCR Diagnostics, Inc. announced the discovery of “Fiber-based Internal Reflection” (FiBIR™), an unprecedented optical phenomenon poised to revolutionize the growing field of fluorescence-based testing. The technology has demonstrated a 50-fold amplification of fluorescent signal making it exceptionally sensitive and cost-effective.

        “FiBIR technology will drive development of next-generation fluorometers to be used across the life science industry in applications ranging from live cell imaging, to PCR, ELISA and Next Generation Sequencing,” says Dr. Boris Rotman, BCR’s Vice President and Chief Scientific Officer.  “BCR plans to offer royalty-based, non-exclusive licenses for both R&D and marketing.”

        “In our prototype fluorometer,” Rotman adds, “FiBIR™ occurs in a proprietary cartridge designed to hold a 12-µl sample.  We envision other physical configurations, such as automated fluorometers using FiBIR™ cartridges for nanoliter samples as well as multi-sample cartridges for high-throughput analysis.  BCR estimates FiBIR™ fluorometers will retail under $1,000.”

        Distinguishing features of FiBIR™ amplification include highly efficient use of excitation light and quantification of fluorescence by digital imaging.

 # # #

About BCR

        Founded in 1994, BCR Diagnostics, Inc. (www.bcrbiotech.com) has been pioneering development of transformative technologies that advance fluorescence-based detection platforms. The R&D leading to the FiBIR™ fluorometer was partially supported by an SBIR Phase I award from the National Institutes of Health.

Contact

        BCR Diagnostics, Inc.
        Jennifer Watkins, Ph.D.
        FIBIR(at)bcrbiotech.com
        (480) 809-6158
News
Apr 18, 2017
Category: General
Posted by: boris123

 

Chandler, Arizona, April 18, 2017

        Taking sterility testing to higher levels, BCR Corp. offers a remarkably simple and rapid Biological Indicator (BI) containing spores of heat-resistant bacteria.

        The BCR-30-min BI™ is the first rapid BI that perfectly matches CDC’s definition of an ideal monitoring system.

 

 

Oct 29, 2014
Category: General
Posted by: boris123

Simple Technology Could Reduce Cost of Fluorescence-based Instrumentation by More than Five-fold


Jan 14, 2011
Category: General
Posted by: boris123

BCR Diagnostics relocates to Chandler, Arizona

Nov 8, 2010
Category: General
Posted by: boris123

BCR Diagnostics awarded $204,630 grant under Qualifying Therapeutic Discovery Project (QTDP) program

Jun 16, 2006
Category: General
Posted by: boris123

BCR Corporation Presents An Innovative Breakthrough Biosensor Platform at National Institutes of Health "Life Sciences Showcase"